Protecting Patients from Deceptive Drug Ads Act
Sponsored By: Senator Sen. Durbin, Richard J. [D-IL]
Introduced
Summary
Curbing deceptive prescription drug promotion on social media and through telehealth. This bill would let the FDA penalize influencers and certain health care actors for knowingly or recklessly false or incomplete online claims, require new payment reporting, and boost FDA monitoring of digital drug promotion.
Show full summary
- Patients and families: Posts that promote covered prescription drugs would need to include the brief summary of side effects, contraindications, and effectiveness like traditional prescription ads, aiming to give consumers clearer safety information.
- Health care providers and social media influencers: Influencers and providers who receive payment to promote covered drugs would face civil penalties for knowingly or recklessly false or materially misleading statements. Those payments must be reported and publicly disclosed under existing drug-payment reporting rules.
- Manufacturers, telehealth platforms, and regulators: The bill would expand who counts as a drug "manufacturer" to include entities that connect patients and prescribers electronically, require updated telehealth rules within 1 year, and direct the FDA to use AI surveillance, hire staff, and form a joint FTC-FDA task force.
*Authorizes $15.0 million per year for fiscal years 2025–2029 to fund FDA market surveillance and related activities.*
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
4 provisions identified: 2 benefits, 2 costs, 0 mixed.
FDA social-media drug ad monitoring
If enacted, the bill would let HHS and FDA monitor prescription drug promotion on social media. The agencies could use AI tools, hire staff, and form a joint FDA–FTC task force. Congress would be asked to fund $15 million each year for 2025 through 2029 to carry out this work.
Public reporting of drug promotion payments
If enacted, payments tied to promoting drugs paid for by Medicare, Medicaid, or CHIP would be reported and posted publicly under the Open Payments program. That includes drug company payments to providers or influencers and provider payments to influencers. A 'covered drug' is any drug for which payment is available under those federal or state programs.
Fines for deceptive drug posts
If enacted, social media influencers and some health care providers could face civil fines for false or misleading posts about certain prescription drugs. The rule would apply when the communicator gets paid and either makes knowingly or recklessly false statements or omits a required short safety summary. It would not cover private patient care or personal opinions. These rules would take effect 180 days after related regulations are finalized.
Telehealth platforms face ad rules
If enacted, online services that place drug ads and connect patients to prescribers would be treated like a drug's manufacturer for advertising rules. That could subject telehealth companies and referral platforms to stricter ad and safety‑summary requirements. Private messages between a clinician and a patient would be excluded. The agency must update rules within one year and the changes would take effect 180 days after final regulations.
Free Policy Watch
You just read the policy. Now see what it costs you.
Pick a topic. PRIA runs your household against live legislation and sends you a free personalized readout.
Pick a topic to get started
Sponsors & CoSponsors
Sponsor
Sen. Durbin, Richard J. [D-IL]
IL • D
Cosponsors
Sen. Marshall, Roger [R-KS]
KS • R
Sponsored 2/20/2025
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govTake It Personal
Get Your Personalized Policy View
Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in